Gocke DJ - Search Results

1

In vivo sequence variation of the human immunodeficiency virus type 1 env gene: evidence for recombination among variants found in a single individual.

Howell RM, Fitzgibbon JE, Noe M, Ren ZJ, Gocke DJ, Schwartzer TA, Dubin DT. Howell RM, et al. Among authors: gocke dj. AIDS Res Hum Retroviruses. 1991 Nov;7(11):869-76. doi: 10.1089/aid.1991.7.869. AIDS Res Hum Retroviruses. 1991. PMID: 1760227

2

Human immunodeficiency virus type 1 pol gene mutations which cause decreased susceptibility to 2',3'-dideoxycytidine.

Fitzgibbon JE, Howell RM, Haberzettl CA, Sperber SJ, Gocke DJ, Dubin DT. Fitzgibbon JE, et al. Among authors: gocke dj. Antimicrob Agents Chemother. 1992 Jan;36(1):153-7. doi: 10.1128/AAC.36.1.153. Antimicrob Agents Chemother. 1992. PMID: 1317143 Free PMC article.

3

In vivo prevalence of azidothymidine (AZT) resistance mutations in an AIDS patient before and after AZT therapy.

Fitzgibbon JE, Howell RM, Schwartzer TA, Gocke DJ, Dubin DT. Fitzgibbon JE, et al. Among authors: gocke dj. AIDS Res Hum Retroviruses. 1991 Mar;7(3):265-9. doi: 10.1089/aid.1991.7.265. AIDS Res Hum Retroviruses. 1991. PMID: 2064825

4

Immunochemical specificity of human antibodies to lipopolysaccharide from the J5 rough mutant of Escherichia coli O111:B4.

Schwartzer TA, Alcid DV, Numsuwan V, Gocke DJ. Schwartzer TA, et al. Among authors: gocke dj. J Infect Dis. 1989 Jan;159(1):35-42. doi: 10.1093/infdis/159.1.35. J Infect Dis. 1989. PMID: 2462603

5

Characterization of the human antibody response to an Escherichia coli O111:B4 (J5) vaccine.

Schwartzer TA, Alcid DV, Numsuwan V, Gocke DJ. Schwartzer TA, et al. Among authors: gocke dj. J Infect Dis. 1988 Nov;158(5):1135-6. doi: 10.1093/infdis/158.5.1135. J Infect Dis. 1988. PMID: 3053926 No abstract available.

6

Immunochemical specificity of cross-reactive antibodies to lipopolysaccharide from Escherichia coli J5.

Schwartzer TA, Alcid DV, Numsuwan V, Gocke DJ. Schwartzer TA, et al. Among authors: gocke dj. J Infect Dis. 1987 May;155(5):1076. doi: 10.1093/infdis/155.5.1076. J Infect Dis. 1987. PMID: 3549920 No abstract available.

7

HTLV-III antibody in commercial immunoglobulin.

Gocke DJ, Raska K Jr, Pollack W, Schwartzer T. Gocke DJ, et al. Lancet. 1986 Jan 4;1(8471):37-8. doi: 10.1016/s0140-6736(86)91914-8. Lancet. 1986. PMID: 2417071 No abstract available.

8

Infective endocarditis in intravenous drug users: a comparison of human immunodeficiency virus type 1-negative and -positive patients.

Nahass RG, Weinstein MP, Bartels J, Gocke DJ. Nahass RG, et al. Among authors: gocke dj. J Infect Dis. 1990 Oct;162(4):967-70. doi: 10.1093/infdis/162.4.967. J Infect Dis. 1990. PMID: 2401795

9

Anti-HIV-1 activity of recombinant and hybrid species of interferon-alpha.

Sperber SJ, Gocke DJ, Haberzettl C, Kuk R, Schwartz B, Pestka S. Sperber SJ, et al. Among authors: gocke dj. J Interferon Res. 1992 Oct;12(5):363-8. doi: 10.1089/jir.1992.12.363. J Interferon Res. 1992. PMID: 1331260

10

Low-dose oral recombinant interferon-alpha A in patients with HIV-1 infection: a blinded pilot study.

Sperber SJ, Gocke DJ, Haberzettl CA, Pestka S. Sperber SJ, et al. Among authors: gocke dj. AIDS. 1993 May;7(5):693-7. AIDS. 1993. PMID: 8100421 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters